Efficacy of a low dose of thalidomide in advanced multiple myeloma

Abstract

Barlogie and his group have demonstrated the efficacy of thalidomide (THAL) in the treatment of advanced multiple myeloma.[1][1] In a more recent expanded follow-up study of 169 patients, the same authors reported that patients receiving more than 42 g THAL in 3 months had higher response and 2-year